Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

VKTXVKTX

Showing 8 of 20 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in VIKING THERAPEUTICS INC

Yes. Connor, Clark & Lunn Investment Management holds 530,607 shares of VKTX (Viking Therapeutics), worth $20.7M, as of its Q2 2026 13F filing. It increased the position by 14,499 shares (+2.8%) from Q1 2026. Connor, Clark & Lunn Investment Management has held VKTX since Q2 2024, across 9 quarterly 13F filings.

Current Value

$20.7M

Current Shares

530,607

Total Value Change

+$10.7M

Total Shares Change

+372,258

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
530,607
+2.8%
$20.7M0.0%$39.01
29
2026-Q1
Decreased
516,108
-0.5%
$16.8M0.0%$32.54
0
2025-Q4
Decreased
518,796
-4.7%
$18.3M0.0%$35.18
0
2025-Q3
Increased
544,201
+21.7%
$14.3M0.0%$26.28
34
2025-Q2
Decreased
447,217
-25.1%
$11.9M0.0%$26.50
0
2025-Q1
Increased
597,515
+59.2%
$14.4M0.1%$24.15
40
2024-Q4
Increased
375,222
+137.0%
$15.1M0.1%$40.24
45
2024-Q3
Increased
158,349
+218.2%
$10M0.0%$63.31
45

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used